应用阿替普酶静脉溶栓联合丁苯酞治疗超早期脑梗死具有良好效果

发布时间：2019-06-07 15:37

【摘要】：为了探讨阿替普酶联合丁苯酞治疗超早期脑梗死的临床效果,以及联合用药用患者预后的相关影响,本研究选择本院100例超早期脑梗死的患者进行观察分析,对照组在常规治疗基础上加用阿替普酶静脉溶栓,观察组在对照组基础上加用丁苯酞静滴,观察并比较两组的神经缺损程度(NIHSS评分)和临床疗效。研究发现,相较治疗前,两组的NIHSS评分在治疗后6 h、24 h和7 d均较低(#p0.05),观察组低于对照组(▲p0.05);观察组的临床总有效率为88%,高于对照组的总有效率70%(▲p0.05)。由此可见,阿替普酶联合丁苯酞治疗超早期脑梗死具有良好的临床疗效,能有效改善患者神经缺损状况,且安全性高。
[Abstract]:In order to investigate the clinical effect of atexin combined with butylphthalide in the treatment of ultra-early cerebral infarction and the related effects on the prognosis of patients with ultra-early cerebral infarction, 100 patients with ultra-early cerebral infarction in our hospital were selected for observation and analysis. On the basis of routine treatment, the control group was treated with atexin intravenous thrombolysis, and the observation group was treated with butylphthalein intravenously on the basis of the control group. The degree of nerve defect (NIHSS score) and clinical efficacy were observed and compared between the two groups. The results showed that the NIHSS scores of the two groups were lower at 24 h and 7 d after treatment than those before treatment (# p0.05), while those in the observation group were lower than those in the control group (鈮，

本文编号：2494902